Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children by Hyams Jeffrey, Crandall Wallace, Kugathasan Subra, Griffiths Anne, Olson Allan, Johanns Jewel, Liu Grace, Travers Suzanne, Heuschkel Robert, Markowitz James, Cohen Stanley, Winter Harland, Veereman-Wauters Gigi, Ferry George, Baldassano Robert, REACH Study Group in Gastroenterology (2007).

[PMID: 17324398] PubMed


The REACH study evaluated the safety and efficacy of infliximab in children with moderately to severely active Crohn's disease.

[ hide abstract ]

Discussed In Paper


Rx Annotations

No dosing information annotated.